National Comprehensive Cancer Network

About NCCN

Now Available! Updated Language Translations of NCCN Guidelines for Hodgkin Lymphoma, Multiple Myeloma, and Non-Hodgkin’s Lymphomas

By Jorge Bacigalupo, Global Business Development Specialist, NCCN

The National Comprehensive Cancer Network® (NCCN®) recently published Chinese, French, German, Italian, Korean, Latin American Portuguese, and Latin American Spanish language translations for the following NCCN Guidelines®:

  • Hodgkin Lymphoma, V2.2016
  • Multiple Myeloma, V3.2016
  • Non-Hodgkin’s Lymphomas V3.2016

The NCCN Guidelines continue to progress as the global standard for clinical practice and policy. The value of NCCN’s evidence-based, expert-derived recommendations to practitioners outside the United States is evident as demonstrated, in part, by the escalating volume and breadth of foreign requests for NCCN Content. Today, more than 417,000 registered users of the NCCN Guidelines on, or nearly 47% of all registered users, report that they reside outside the United States. Moreover, there is substantial and increasing global interest in having NCCN Guidelines translated into a variety of languages. Last year, requests for translations of NCCN Content continued to grow, with 35 countries seeking NCCN Guidelines resources, including in their native languages. 

Currently, there are more than 80 translations of NCCN Guidelines available on and the Virtual Library of NCCN Guidelines Mobile App. Translations of NCCN Guidelines are available in Brazilian Portuguese, Chinese, Japanese, Latin American Spanish, and South Korean. Adaptations of NCCN Guidelines are available for use in Asia, Latin America, the Middle East, and Russia. To access these resources, or to learn more about NCCN global initiatives, please visit

If you would like to learn more about translations or regional adaptations of the NCCN Guidelines or other NCCN Content, as well as other global programming opportunities, please contact Jorge Bacigalupo.